How big is the Migraine Drugs Market ?
Global Migraine Drugs Market reached USD 10,972.1 million in 2022 and is projected to witness lucrative growth by reaching up to USD 26,618.96 million by 2031
Who are the key players in Migraine Drugs Market ?
Key players are Abbott Laboratories, AbbVie Inc, Allergan Plc., AstraZeneca PLC., Eisai Co., Ltd., Endo International Plc., GlaxoSmithKline Plc., Merck & Co., Inc., Pfizer Inc and Johnson & Johnson.